Serum complement C3 strongly correlates with whole-body insulin sensitivity in rheumatoid arthritis

Francesco Ursini1, Salvatore D'Angelo2, Emilio Russo3

  • 1Department of Health Sciences, University of Catanzaro "Magna Graecia", Catanzaro, Italy. francesco.ursini@yahoo.it.

Insights

Rheumatoid arthritis patients show a strong link between inflammation and insulin resistance. Complement C3 levels correlate with insulin sensitivity, aiding in identifying at-risk individuals.

Area of Science:

  • Rheumatology
  • Endocrinology
  • Immunology

Background:

  • Rheumatoid arthritis (RA) is associated with increased cardiovascular disease (CVD) risk.
  • This risk stems from a combination of traditional risk factors, like insulin resistance, and chronic inflammation.
  • Understanding the interplay between inflammation and metabolic health in RA is crucial for CVD prevention.

Purpose of the Study:

  • To investigate the relationship between inflammatory markers and insulin sensitivity in patients with rheumatoid arthritis.
  • To identify specific inflammatory indicators that correlate with impaired insulin sensitivity.

Main Methods:

  • Forty non-diabetic rheumatoid arthritis patients were enrolled.
  • Standard anthropometric measurements, laboratory tests, and oral glucose tolerance tests (OGTT) were performed.
  • Insulin sensitivity index (ISI) was calculated using dynamic glucose and insulin values from the OGTT.

Main Results:

  • Insulin sensitivity index (lnISI) showed inverse correlations with age, BMI, waist circumference, systolic blood pressure, ESR, CRP, and complement C3.
  • In non-obese patients, lnISI correlated with age, BMI, CRP, and C3.
  • Multiple regression analysis revealed that BMI and complement C3 significantly predicted lnISI, explaining 38.2% of the variance. In non-obese patients, only C3 was a significant predictor (32.2% variance).
  • A complement C3 cutoff of 1.22 g/L effectively identified insulin-resistant RA patients (67% sensitivity, 79% specificity).

Conclusions:

  • Complement C3 is a significant correlate of insulin sensitivity in rheumatoid arthritis patients.
  • This association holds true for both obese and non-obese individuals.
  • Complement C3 may serve as a valuable biomarker for assessing insulin resistance in RA.
Abstract